A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment

Clinical trial NCT06539338 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06539338
Sponsor: Kite, A Gilead Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphomas Non-Hodgkin's B-Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma

Start date: 2024-09-20
Primary completion: 2026-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.